Pembrolizumab
Category: CancerPembrolizumab Overview
Pembrolizumab (formerly lambrolizumab, brand name Keytruda) is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer.[3] It is given by slow injection into a vein.[3] Common side effects include fatigue, musculoskeletal pain, decreased appetite, itchy skin (pruritus), diarrhea, nausea, rash, fever (pyrexia), cough, difficulty breathing (dyspnea), constipation, ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pembrolizumab
Recent Pembrolizumab Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Pembrolizumab
- Powder, For Injection Solution, Lyophilized Powder: 50mg
Other drugs which contain Pembrolizumab or a similar ingredient: (1 result)
- KEYTRUDA Pembrolizumab2 discussions
Related Pembrolizumab Topics:
Pembrolizumab and Glutathione
My husband is in immunotherapy, undergoing 1 infusion of pembrolizumab ('Keytruda') every three weeks. Is it hel...
My husband is in immunotherapy, undergoing 1 infusion of pembrolizumab ('Keytruda') every three weeks. Is it hel...